Detalhe da pesquisa
1.
Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.
J Infect Dis
; 226(3): 431-440, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584386
2.
Long-term hepatic function of patients with compensated cirrhosis following successful direct-acting antiviral treatment for hepatitis C virus infection.
J Gastroenterol Hepatol
; 37(2): 371-377, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618379
3.
Long-term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct-acting antivirals.
J Gastroenterol Hepatol
; 37(1): 190-199, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374128
4.
Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers.
J Infect Chemother
; 28(6): 802-805, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288023
5.
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication.
Clin Infect Dis
; 71(11): 2840-2848, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31777940
6.
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.
Liver Int
; 40(7): 1578-1589, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32304611
7.
Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis.
Hepatol Res
; 50(2): 174-181, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31634412
8.
Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study.
Hepatol Res
; 49(6): 617-626, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30849206
9.
Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis.
Hepatol Res
; 47(3): E120-E131, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27142311
10.
Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C.
Hepatol Res
; 46(3): E174-80, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26189962
11.
Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies.
Hepatol Res
; 46(10): 992-1001, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26670363
12.
Two cases of malignant lymphoma with reactivation of resolved hepatitis B virus infection after bendamustine hydrochloride monotherapy.
Nihon Shokakibyo Gakkai Zasshi
; 113(9): 1582-7, 2016 09.
Artigo
em Japonês
| MEDLINE | ID: mdl-27593368
13.
Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C.
Hum Genet
; 134(3): 279-89, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25515861
14.
Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection.
J Gastroenterol Hepatol
; 30(12): 1759-67, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26095167
15.
Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C.
J Gastroenterol Hepatol
; 30(8): 1309-16, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25777545
16.
[Hypoxemia due to pulmonary tumor microembolisms from a hepatocellular carcinoma: a case report].
Nihon Shokakibyo Gakkai Zasshi
; 112(6): 1060-6, 2015 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-26050730
17.
Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus-related liver cirrhosis: A multicenter retrospective study in Japan.
Hepatol Res
; 44(9): 983-92, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24400682
18.
Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.
J Gastroenterol Hepatol
; 29(9): 1728-35, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24731162
19.
Interferon-beta plus ribavirin therapy can be safely and effectively administered to elderly patients with chronic hepatitis C.
J Infect Chemother
; 20(8): 489-92, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24857619
20.
Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.
J Hepatol
; 59(2): 205-12, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23542346